Industry Overview                               

Angioplasty balloons market valued at $5,325.6 million in 2025 and is projected to reach $7,309.6 million by 2035, growing at a CAGR of 3.3% during the forecast period (2026-2035). The global angioplasty balloons market is progressing steadily as cardiovascular disease prevalence continues to rise and healthcare systems prioritize minimally invasive treatment approaches. Growth is being driven by the increasing adoption of percutaneous coronary interventions (PCI), supported by advancements in balloon catheter technologies that enhance precision, flexibility, and safety. Demand is further reinforced by the growing aging population and the expanding burden of lifestyle-related conditions such as hypertension and atherosclerosis. As clinicians emphasize faster recovery times and improved procedural outcomes, angioplasty balloons remain a critical component in interventional cardiology. Continuous innovation in drug-coated and specialty balloons is also contributing to improved long-term efficacy and reduced restenosis rates.

Market Dynamics

Rising Prevalence of Cardiovascular Diseases Driving Procedure Volumes

The increasing global incidence of cardiovascular disorders, including coronary artery disease and peripheral artery disease, is significantly boosting demand for angioplasty procedures. Healthcare providers are increasingly relying on balloon-based interventions as a first-line treatment for vessel dilation due to their minimally invasive nature and shorter hospital stays. Growing awareness regarding early diagnosis and treatment is encouraging patients to opt for interventional procedures, further supporting market growth. Additionally, favorable reimbursement frameworks in developed regions are enabling broader patient access to angioplasty treatments. This expanding patient pool continues to act as a major catalyst for the global angioplasty balloons market.

Technological Advancements in Drug-Coated and Specialty Balloons

Innovations in angioplasty balloon design, particularly drug-coated balloons (DCBs) and cutting or scoring balloons, are enhancing procedural effectiveness and clinical outcomes. Drug-coated balloons are gaining traction due to their ability to deliver antiproliferative drugs directly to the arterial wall, reducing the risk of restenosis without leaving a permanent implant. Manufacturers are focusing on improving coating technologies, balloon deliverability, and lesion-crossing capabilities to address complex vascular conditions. These advancements are expanding the applicability of angioplasty balloons across coronary and peripheral interventions. As a result, the integration of advanced balloon technologies is emerging as a key growth driver in the market.

Market Segmentation

• Based on the product type, the market is segmented into cutting balloon catheter, drug coated balloon catheter, normal balloon catheter and scoring balloon catheter.
• based on the application, the market is segmented into coronary angioplasty, peripheral angioplasty, carotid angioplasty, renal artery angioplasty and venous angioplasty.
• based on the end user, the market is segmented into hospitals, ambulatory surgical centers and other.

Drug-Coated Balloon Catheter Segment to Dominate the Market with the Largest Share

In the global angioplasty balloons market, the drug-coated balloon catheter segment is expected to account for the largest market share, driven by its ability to reduce restenosis rates and improve long-term patient outcomes. These balloons deliver antiproliferative drugs directly to the vessel wall during angioplasty, minimizing the need for permanent implants such as stents. The increasing prevalence of cardiovascular diseases, rising preference for minimally invasive procedures, and growing clinical evidence supporting the efficacy of drug-coated balloons are key factors driving segment growth. Additionally, ongoing advancements in coating technologies and drug delivery mechanisms are enhancing procedural success rates and expanding clinical applications. These factors collectively reinforce the dominance of the drug-coated balloon catheter segment within the overall market.

Coronary Angioplasty: A Key Segment in Market Growth

The coronary angioplasty segment plays a pivotal role in driving growth within the angioplasty balloons market, owing to the high global burden of coronary artery disease and the increasing number of interventional cardiology procedures. Coronary angioplasty remains one of the most commonly performed procedures for restoring blood flow in blocked coronary arteries, particularly in cases of acute myocardial infarction and chronic ischemic conditions. The growing aging population, rising incidence of lifestyle-related risk factors such as diabetes and hypertension, and increasing awareness of early diagnosis and treatment are significantly boosting demand in this segment. Furthermore, advancements in balloon catheter technologies, including improved flexibility, deliverability, and precision, are enhancing procedural efficiency and patient outcomes. Together, these factors position coronary angioplasty as a major contributor to overall market expansion.

Regional Outlook

The global angioplasty balloons market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

Expanding Healthcare Infrastructure Across Asia-Pacific

Asia-Pacific is witnessing robust growth in the angioplasty balloons market due to improving healthcare infrastructure and increasing access to advanced cardiovascular treatments. Governments and private healthcare providers are investing in the development of specialized cardiac care centers equipped with modern catheterization laboratories. Rising healthcare expenditure and growing medical tourism are further contributing to the adoption of angioplasty procedures in the region. Additionally, increasing physician training and awareness regarding advanced interventional techniques are supporting the use of next-generation balloon catheters. This regional expansion is creating new growth opportunities for global market players.

North America Region Dominates the Market with Major Share

North America holds a dominant position in the angioplasty balloons market, supported by a high prevalence of cardiovascular diseases and widespread adoption of advanced interventional procedures. The region benefits from well-established healthcare infrastructure and the early adoption of innovative medical technologies, including drug-coated and specialty balloons. Strong presence of leading medical device manufacturers and continuous investment in research and development are further strengthening market growth. Additionally, favorable reimbursement policies and high healthcare spending enable greater accessibility to angioplasty procedures. These factors collectively reinforce North America’s leadership in the global market.

Market Players Outlook

The major companies operating in the global angioplasty balloons market includes Abbott Laboratories, Boston Scientific Corporation, B. Braun Melsungen AG, Medtronic plc, Terumo Corporation, among others. Market players are leveraging partnerships, collaborations, mergers and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Developments

• In May 2025, Medtronic plc introduced an advanced drug-coated balloon designed for peripheral artery disease, focusing on improved drug delivery efficiency and enhanced vessel patency outcomes.
• In March 2025, Boston Scientific Corporation expanded its portfolio of specialty angioplasty balloons with a next-generation scoring balloon aimed at treating complex calcified lesions with higher precision and reduced procedural complications.

The Report Covers

• Market value data analysis of 2025 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global angioplasty balloons Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.